Shenzhen - Delayed Quote CNY

Landfar Bio-medicine Co., Ltd (000504.SZ)

6.93 +0.09 (+1.32%)
At close: April 26 at 3:04 PM GMT+8
Key Events
Loading Chart for 000504.SZ
DELL
  • Previous Close 6.84
  • Open 7.25
  • Bid 6.93 x --
  • Ask 6.94 x --
  • Day's Range 6.72 - 6.94
  • 52 Week Range 5.26 - 13.17
  • Volume 2,294,200
  • Avg. Volume 5,010,756
  • Market Cap (intraday) 2.287B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) --
  • EPS (TTM) -0.04
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 23, 2004
  • 1y Target Est --

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. The company operates through Biomedicine, and Energy Saving and Environmental Protection segments. The Biomedicine segment engages in the provision of stem cell storage and technical services; stem cell therapy research; medical device procurement and sales, etc. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was founded in 1991 and is based in Changsha, China.

www.landfar.cn

512

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 000504.SZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

000504.SZ
40.26%
SSE Composite Index
3.82%

1-Year Return

000504.SZ
41.22%
SSE Composite Index
5.40%

3-Year Return

000504.SZ
52.21%
SSE Composite Index
11.10%

5-Year Return

000504.SZ
48.36%
SSE Composite Index
1.13%

Compare To: 000504.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000504.SZ

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    2.29B

  • Enterprise Value

    2.12B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.31

  • Price/Book (mrq)

    160.41

  • Enterprise Value/Revenue

    14.26

  • Enterprise Value/EBITDA

    -110.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.57%

  • Return on Assets (ttm)

    -4.58%

  • Return on Equity (ttm)

    -32.71%

  • Revenue (ttm)

    148.7M

  • Net Income Avi to Common (ttm)

    -12.75M

  • Diluted EPS (ttm)

    -0.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    219.73M

  • Total Debt/Equity (mrq)

    253.42%

  • Levered Free Cash Flow (ttm)

    40.71M

Company Insights: 000504.SZ

People Also Watch